Publications
Résultats 501 à 510 sur 558 Publications
| Titre | Auteurs | Année | Revue |
|---|---|---|---|
| An Intervention Framework and Toolkit to Ease the Decision-making and Transition to Non-driving for Persons with Dementia and their Family Caregivers | |||
| An endothelial link between the benefits of physical exercise in dementia | Trigiani, L. J., & Hamel, E. | 2017 | Journal of Cerebral Blood Flow and Metabolism |
| An action plan to face the challenge of dementia: INTERNATIONAL STATEMENT ON DEMENTIA from IAP for Health | Chertkow, H., on behalf of the Research Executive Committee of the Canadian Consortium on Neurodegeneration in Aging and the International IAP committee on Dementia | 2018 | The Journal of Prevention of Alzheimer’s Disease |
| Amyloidogenic regions in beta-strands II and III modulate the aggregation and toxicity of SOD1 in living cells | McAlary L., Nan J.R., Shyu C., Sher M., Plotkin S.S*, & Cashman N.R* | 2024 | Open Biol |
| Amyloid ß Impacts Future Freezing of Gait in Parkinson’s Disease Via White Matter Hyperintensities | Dadar M, Miyasaki J, Duchesne S*, Camicioli R* | 2020 | bioRxiv |
| Amyloid beta plaque accumulation with longitudinal [18F]AZD4694 PET | Therriault, J.**, Lussier, F. Z., Tissot, C.**, Chamoun, M., Stevenson, J., Rahmouni, N.**, Pallen, V., Bezgin, G., Servaes, S., Kunach, P.**, Wang, Y. T.**, Fernandez-Arias, J.**, Vermeiren, M., Pascoal, T. A., Massarweh, G., Vitali, P., Soucy, J. P., Saha-Chaudhuri, P., Gauthier, S.*, & Rosa-Neto, P.* | 2023 | Alzheimer's & dementia |
| Alzheimer’s biomarkers from multiple modalities selectively discriminate clinical status: Relative importance of salivary metabolomics panels, genetic, lifestyle, cognitive, functional health and demographic risk markers | Sapkota, S., Huan, T., Tran T., Zheng, J., Camicioli, R., Li, L. & Dixon, R.A. | 2018 | Frontiers in Aging Neuroscience |
| Alzheimer’s environmental and genetic risk scores are differentially associated with general cognitive ability and dementia severity. | Andrews, S.J., McFall, G.P.**, Dixon, R.A.**, Cherbuin, N., Eramudugolla, R., Anstey, K.J. | 2019 | Alzheimer Disease & Associated Disorders |
| Alzheimer’s Disease Neuroimaging Initiative. Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease. | Pascoal T.A.**, Mathotaarachchi S.**, Shin M.**, Park A.Y., Mohades S., Benedet A.L.**, Kang M.S., Massarweh G., Soucy J.P.**, Gauthier S.**, Rosa-Neto P.** | 2018 | European Journal of Nuclear Medicine and Molecular Imaging |
| Alzheimer Disease, biomarkers, and clinical symptoms – Quo Vadis? | Montero-Odasso M*, Ismail Z*, Camicioli R* | 2020 | JAMA Neurology |
Résultats 501 à 510 sur 558 Publications